Menu
Close
Measurement for our planet
Close
Measurement for our planet

Receive regular emails from NPL to get a glimpse of our activities and see how our experts are informing and influencing scientific debate

  • Home
  • News
  • Accelerating the digitalisation of pharmaceutical manufacturing

Accelerating the digitalisation of pharmaceutical manufacturing

NPL joins the Medicines Manufacturing Innovation Centre’s consortium to drive standardisation and adoption of digital medicines manufacturing technology

NPL, alongside digital SMEs Stream Native and Wyoming, are the latest members to join a CPI led consortium which will bring a range of digital and data expertise to projects supporting the UK pharmaceutical sector. The consortium will help deliver the innovation required for a digital manufacturing future for the pharmaceutical and life science sector. The Medicines Manufacturing Innovation Centre is a collaboration between CPI, the University of Strathclyde, UKRI, Scottish Enterprise, AstraZeneca and GSK, and aims to develop the medicines manufacturing processes of the future, demonstrating at scale step-change innovation technology.

The collaboration will enable even greater exploitation of NPL’s metrology expertise which has long played a leading role in the development of technologies in advanced manufacturing including pharmaceutical applications. Working as part of this newly expanded consortium, researchers at NPL will grow their contribution to the use of digital technologies in the development, manufacture and supply of medicines to deliver faster solutions to challenges in both small molecule and advanced therapeutics manufacturing.

To enable continued progress in the shift away from a dependence on end product quality control, to quality assurance of the entire medicines manufacturing process, requires the ability to trace information across the end-to-end supply chain and to end users. This approach will increase the volume and complexity of data produced as the industry moves to digitalisation of medicines manufacturing. Working with Medicines Manufacturing Innovation Centre partners and the pharmaceutical industry, NPL will ensure that measurement methods and data frameworks are standardised and produce data of the highest quality, increasing confidence in the manufacture, supply, analysis and control of increasingly complex medicines, to take event greater advantage of the opportunities available in the pharmaceutical industry.

Both Michael Adeogun, Head of Life Sciences and Health and Mark Summers, Head of Advanced Manufacturing at the National Physical Laboratory said: “NPL’s metrology expertise plays a vital role in enabling people to live longer, healthier, more prosperous lives, delivering health equality for all. Across the life sciences ecosystem, our research is helping to accelerate innovation in disease diagnosis, drive improved treatment approaches and helping to fight current and future pandemics. We are delighted to be part of the expanding CPI consortium, with a focus on delivery of the significant opportunities available through the digitalisation of advanced manufacturing in the pharmaceutical sector which will help to cement the UK’s global leadership in life science."

Find out more: https://lnkd.in/eZ7X-kpD

 

21 Dec 2021